Peter Kaiser, Chief Development Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 2,974 shares at $7.17 ($21K) on 2025-05-23, disclosed to the SEC on 2025-05-27.
Open-market sale of $21k OCUL by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OCUL | SELL | 2026-05-28 | $24K | — | Filing → |
| OCUL | SELL | 2026-02-25 | $23K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $36K | — | Filing → |